Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.09B | 2.55B | 2.83B | 3.27B | 2.65B |
Gross Profit | 1.08B | 605.13M | 1.12B | 1.37B | 1.02B |
EBITDA | 511.27M | 40.90M | 640.77M | 842.99M | 619.66M |
Net Income | 279.91M | -75.48M | 357.52M | 528.06M | 402.46M |
Balance Sheet | |||||
Total Assets | 4.79B | 4.64B | 5.85B | 7.15B | 5.97B |
Cash, Cash Equivalents and Short-Term Investments | 1.58B | 971.32M | 2.01B | 2.81B | 2.52B |
Total Debt | 2.19B | 2.18B | 2.20B | 2.24B | 2.29B |
Total Liabilities | 4.03B | 4.07B | 4.59B | 5.49B | 4.97B |
Stockholders Equity | 636.24M | 423.76M | 556.46M | 975.22M | 911.77M |
Cash Flow | |||||
Free Cash Flow | 697.33M | 136.37M | 784.47M | 826.38M | 511.64M |
Operating Cash Flow | 742.83M | 164.66M | 833.98M | 866.08M | 575.93M |
Investing Cash Flow | 134.07M | -38.32M | -56.44M | -39.06M | -62.94M |
Financing Cash Flow | -439.67M | -1.57B | -1.38B | 195.84M | -547.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $5.18B | 19.17 | 50.56% | 3.66% | 10.54% | 92.31% | |
77 Outperform | $7.42B | 27.85 | 23.44% | ― | 56.04% | 58.58% | |
73 Outperform | $5.73B | 32.51 | 39.98% | 3.52% | 42.85% | 1398.33% | |
72 Outperform | $4.64B | 16.07 | 16.69% | ― | 67.71% | 19.42% | |
70 Outperform | $6.50B | 32.73 | 96.33% | 0.54% | 16.04% | 60.32% | |
70 Neutral | $5.67B | 27.89 | 17.59% | 1.75% | 10.27% | 88.77% | |
68 Neutral | $17.10B | 11.44 | 9.70% | 3.58% | 11.11% | -4.78% |
On May 8, 2025, Lazard held its Annual Meeting of shareholders where three proposals were considered. The election of directors saw Peter Harrison and Dan Schulman receiving significant votes, while the non-binding advisory vote on executive compensation and the ratification of Deloitte & Touche LLP as the independent accounting firm were also addressed. The outcomes of these votes reflect the shareholders’ stance on the company’s governance and financial oversight, potentially influencing Lazard’s operational strategies and stakeholder relations.
The most recent analyst rating on (LAZ) stock is a Hold with a $52.00 price target. To see the full list of analyst forecasts on Lazard stock, see the LAZ Stock Forecast page.